Digital health company Zerigo Health has announced today the appointment of Lisa Rometty as its new Chief Executive Officer (CEO).
Rometty joins Zerigo from CVS Kidney Care where she served as President.
In this role, Rometty led the development of a personalised approach to kidney disease identification, care management and home-first treatment.
Previously, Rometty served as President of Global Client Solutions at Syneos Health, where she led the strategy and global expansion of the company’s commercial partnerships and created new growth models.
Glen Tullman, Executive Chairman of Zerigo Health, Chief Executive Officer of Transcarent, and Managing Partner at 7wireVentures, said:
“Lisa’s go-to-market experience and success building home health ecosystems for consumers living with chronic conditions will be instrumental in scaling Zerigo.
“The market is searching for cost-effective alternatives to expensive biologics, and we are excited to have Lisa driving our mission to empower people living with chronic skin conditions with convenient, affordable, and personalised care.”
Zerigo Health’s connected phototherapy solution enables people to better manage their chronic skin conditions, while also helping to reduce the costs and risks associated with expensive pharmaceutical treatments.
By coupling its FDA-cleared, handheld NB-UVB light device with a smartphone app and experienced team of care providers, Zerigo enables them to self-administer clinical light therapy, cost-effectively, at or wherever they may be.
Rometty said:
“I am excited to join the Zerigo Health team at such an important time in the company’s development.
“People living with chronic skin conditions deserve to have more convenient and effective treatment options that give them the freedom to get back to life.
“We have a significant opportunity to make the home the preferred site of care for consumers and to create outsized value throughout the healthcare ecosystem.”
